がん治療施設の世界市場

がん治療施設の世界市場は2030年までに725億米ドルに達する見込み

2024年に484億米ドルと推定されるがん治療施設の世界市場は、分析期間2024-2030年にCAGR 7.0％で成長し、2030年には725億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるがん手術は、CAGR 7.7%を記録し、分析期間終了までに410億米ドルに達すると予測されます。化学療法分野の成長率は、分析期間を通じてCAGR 6.8％と推定されます。

米国市場は132億米ドルと推定、中国はCAGR 11.0％で成長予測

米国のがん治療施設市場は、2024年に132億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに152億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.4%と6.8%と予測されています。欧州では、ドイツがCAGR 4.6%で成長すると予測されています。

世界のがん治療施設市場- 主要動向と促進要因のまとめ

なぜ先進的ながん治療施設の需要が伸びているのか？

世界のがん罹患率の増加により、包括的かつ専門的な治療を提供する最先端のがん治療施設に対する需要が高まっています。人口の高齢化、ライフスタイルの変化、環境要因によってがんの発生率が上昇する中、ヘルスケア機関は最先端の治療技術を備えた高度腫瘍学センターに多額の投資を行っています。これらの施設は、早期診断、精密治療、集学的治療を提供し、患者の転帰を改善する上で極めて重要です。

価値ベースのヘルスケアへの移行も、がん治療施設の開発を形成しています。政府や民間ヘルスケアプロバイダーは、先進的な診断ツール、ロボット手術、標的治療、支持療法サービスをがんセンターに統合することに注力しています。さらに、陽子線治療、AIを活用した診断、個別化医療の台頭により、既存の治療センターのアップグレードや腫瘍専門病院の新設への投資が世界中で活発化しています。

技術の進歩は、がん治療センターをどのように変革しているのか？

がん治療施設におけるテクノロジーの統合は、患者ケアに革命をもたらし、治療効果を高めています。AIと機械学習は現在、がんの早期発見に利用されており、腫瘍医が腫瘍を最も早期で治療可能な段階で特定できるようになっています。さらに、陽子線治療などの精密放射線治療は、がん細胞に高線量の放射線を照射しながら、健康な組織へのダメージを最小限に抑えています。

もう一つの重要な進歩は、ロボット支援手術の利用です。ロボット支援手術は、より精度の高い低侵襲手術を可能にし、回復時間を短縮し、手術成績を向上させる。遠隔医療やデジタルヘルスプラットフォームもまた、専門家であるがん専門医へのアクセスを拡大し、特に十分な治療を受けていない地域の患者にとって、遠隔地からの診察やセカンドオピニオンを可能にしています。さらに、研究主導型のがんセンターでは、患者の遺伝子構成に基づいて治療計画をカスタマイズするためにゲノム配列決定を統合しており、より効果的で個別化された治療につながっています。

市場動向はがん治療施設開拓にどのような影響を与えているか？

包括的ながん治療モデルへのシフトにより、化学療法、放射線療法、免疫療法、支持療法などの治療法を組み合わせて提供する統合がんセンターの設立が進んでいます。この総合的なアプローチにより、患者はシームレスで協調的なケアを受けられるようになり、生存率と生活の質が向上します。

さらに、新興市場におけるがん治療施設の拡大は大きな動向であり、政府や民間投資家がアジア、中東・アフリカに高度な腫瘍病院を建設しています。専門的ながん治療への需要が高まる中、官民パートナーシップはヘルスケアのギャップを埋め、世界クラスのがん医療サービスへのアクセスを拡大する上で重要な役割を果たしています。さらに、ウェルネス、快適性、メンタルヘルスサポートに重点を置いた患者中心の設計原則が最新のがんセンターに取り入れられ、全体的な治療体験の向上が図られています。

市場の主な成長促進要因は何か？

がん治療施設市場の成長の原動力は、がん罹患率の増加、急速な技術進歩、専門的ながん治療の必要性です。AI、ロボット工学、精密医療への投資が治療成果を高め、最新のがんセンターの能力を拡大しています。価値観に基づくヘルスケアの推進と全人的治療アプローチの統合も市場の拡大に寄与しています。

さらに、腫瘍学インフラへの政府資金や民間投資は、特に新興経済諸国において新たながん治療センターの開発を加速させています。遠隔医療やデジタル腫瘍学サービスの台頭は、専門家による治療への患者のアクセスをさらに変化させ、遠隔地に住む人々でさえ高度ながん治療の恩恵を受けられるようにしています。がん研究と治療手法が進化を続ける中、調査手法市場は今後も持続的な成長が見込まれます。

セグメント

治療タイプ（がん手術、化学療法、放射線療法、ホルモン療法、その他の治療タイプ）、がんタイプ（血液がん、乳がん、前立腺がん、消化器がん、婦人科がん、呼吸器／肺がん、その他のがんタイプ）、提供者（病院、がん治療センター）

調査対象企業の例

• Asan Medical Center
• Charite-Universitatsmedizin Berlin
• Cleveland Clinic
• Dana-Farber Cancer Institute
• Gustave Roussy
• Hospital of the University of Pennsylvania
• Hospital Universitari Vall d'Hebron
• Institut Curie
• Johns Hopkins Hospital
• Mayo Clinic
• MD Anderson Cancer Center
• Memorial Sloan Kettering Cancer Center
• National Cancer Center Hospital
• Peter MacCallum Cancer Centre
• Samsung Medical Center
• Seoul National University Hospital
• Singapore General Hospital
• The Royal Marsden NHS Foundation Trust
• University Hospital Heidelberg
• University of Michigan Hospitals-Michigan Medicine

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Cancer Treatment Facilities Market to Reach US$72.5 Billion by 2030

The global market for Cancer Treatment Facilities estimated at US$48.4 Billion in the year 2024, is expected to reach US$72.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Cancer Surgery, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$41.0 Billion by the end of the analysis period. Growth in the Chemotherapy segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.2 Billion While China is Forecast to Grow at 11.0% CAGR

The Cancer Treatment Facilities market in the U.S. is estimated at US$13.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$15.2 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Cancer Treatment Facilities Market - Key Trends & Drivers Summarized

Why Is the Demand for Advanced Cancer Treatment Facilities Growing?

The increasing global burden of cancer has led to a heightened demand for state-of-the-art cancer treatment facilities that offer comprehensive and specialized care. With cancer rates rising due to aging populations, lifestyle changes, and environmental factors, healthcare institutions are investing heavily in advanced oncology centers equipped with cutting-edge treatment technologies. These facilities are crucial in delivering early diagnosis, precision treatments, and multidisciplinary care to improve patient outcomes.

The transition toward value-based healthcare is also shaping the development of cancer treatment facilities. Governments and private healthcare providers are focusing on integrating advanced diagnostic tools, robotic surgeries, targeted therapies, and supportive care services into cancer centers. Additionally, the rise of proton therapy, AI-driven diagnostics, and personalized medicine has fueled investments in upgrading existing treatment centers and building new specialized oncology hospitals worldwide.

How Are Technological Advancements Transforming Cancer Treatment Centers?

The integration of technology in cancer treatment facilities is revolutionizing patient care and enhancing treatment efficacy. AI and machine learning are now being used for early cancer detection, enabling oncologists to identify tumors at their earliest and most treatable stages. Moreover, precision radiation therapy, such as proton beam therapy, is minimizing damage to healthy tissues while delivering high-dose radiation to cancer cells.

Another key advancement is the use of robotic-assisted surgeries, which allow for minimally invasive procedures with higher precision, reducing recovery time and improving surgical outcomes. Telemedicine and digital health platforms are also expanding access to expert oncologists, enabling remote consultations and second opinions, particularly for patients in underserved regions. Additionally, research-driven cancer centers are integrating genomic sequencing to customize treatment plans based on a patient’s genetic makeup, leading to more effective and personalized therapies.

How Are Market Trends Impacting Cancer Treatment Facility Development?

The shift toward comprehensive cancer care models has led to the establishment of integrated cancer centers that offer a combination of treatment modalities, including chemotherapy, radiation, immunotherapy, and supportive care. This holistic approach ensures that patients receive seamless and coordinated care, improving survival rates and quality of life.

Additionally, the expansion of cancer treatment facilities in emerging markets is a major trend, with governments and private investors building advanced oncology hospitals in Asia, the Middle East, and Africa. As demand for specialized cancer care grows, public-private partnerships are playing a key role in bridging healthcare gaps and expanding access to world-class oncology services. Moreover, patient-centric design principles are being incorporated into modern cancer centers, with a focus on wellness, comfort, and mental health support to improve the overall treatment experience.

What Are the Key Growth Drivers in the Market?

The growth in the cancer treatment facilities market is driven by increasing cancer prevalence, rapid technological advancements, and the need for specialized oncology care. Investments in AI, robotics, and precision medicine are enhancing treatment outcomes and expanding the capabilities of modern cancer centers. The push for value-based healthcare and the integration of holistic treatment approaches are also contributing to the market’s expansion.

Furthermore, government funding and private investments in oncology infrastructure are accelerating the development of new cancer treatment centers, particularly in emerging economies. The rise of telemedicine and digital oncology services is further transforming patient access to expert care, ensuring that even remote populations can benefit from advanced cancer treatments. As cancer research and treatment methodologies continue to evolve, the cancer treatment facilities market is expected to experience sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Cancer Treatment Facilities market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy, Other Treatment Types); Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, Other Cancer Types); Provider (Hospitals, Cancer Treatment Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Asan Medical Center
• Charite - Universitatsmedizin Berlin
• Cleveland Clinic
• Dana-Farber Cancer Institute
• Gustave Roussy
• Hospital of the University of Pennsylvania
• Hospital Universitari Vall d'Hebron
• Institut Curie
• Johns Hopkins Hospital
• Mayo Clinic
• MD Anderson Cancer Center
• Memorial Sloan Kettering Cancer Center
• National Cancer Center Hospital
• Peter MacCallum Cancer Centre
• Samsung Medical Center
• Seoul National University Hospital
• Singapore General Hospital
• The Royal Marsden NHS Foundation Trust
• University Hospital Heidelberg
• University of Michigan Hospitals-Michigan Medicine

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Cancer Treatment Facilities - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Cancer Incidence Driving Demand for Advanced Treatment Facilities
  • Expansion of Multidisciplinary Cancer Care Centers Enhancing Patient Outcomes
  • Increased Investment in Oncology Infrastructure in Emerging Economies
  • Growing Focus on Outpatient and Ambulatory Cancer Treatment Centers
  • Integration of Advanced Imaging and Radiation Therapy Equipment in Modern Facilities
  • Shift Toward Personalized and Genomic-Based Treatment Protocols
  • Rise of Comprehensive Cancer Hospitals Offering End-to-End Services
  • Growing Role of Tele-Oncology and Remote Treatment Platforms
  • Adoption of AI and Big Data for Treatment Planning and Facility Management
  • Increased Public-Private Partnerships in Oncology Care Infrastructure
  • Expansion of Daycare Chemotherapy and Immunotherapy Services
  • Wider Access to Proton and Heavy Ion Therapy at Specialized Facilities
  • Growing Focus on Palliative Care and Support Services in Cancer Centers
  • Hospital Accreditation and Certification Trends Supporting Quality Enhancement
  • Integration of Electronic Health Records and Oncology Information Systems Improving Workflow
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cancer Treatment Facilities Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cancer Treatment Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hormone Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Gynecologic Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Gynecologic Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Gynecologic Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Respiratory / Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Respiratory / Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Respiratory / Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Blood Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Blood Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Blood Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Gastrointestinal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Gastrointestinal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Gastrointestinal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Cancer Treatment Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Cancer Treatment Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Cancer Treatment Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• JAPAN
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• CHINA
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• EUROPE
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Cancer Treatment Facilities by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• FRANCE
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• GERMANY
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Cancer Treatment Facilities by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• INDIA
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Cancer Treatment Facilities by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Cancer Treatment Facilities by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
• AFRICA
  • Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030

IV. COMPETITION